Lack of Proper Child Passenger Restraints Seen in Majority of Fatal Car Crashes
By Lori Solomon HealthDay Reporter
Medically reviewed by Drugs.com

TUESDAY, Aug. 12, 2025 -- Nearly 70 percent of U.S. children in car crashes with a fatality are not using proper child passenger restraints, according to a study published online July 31 in Traffic Injury Prevention.
Arthi S. Kozhumam, from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues identified child, driver, vehicle, neighborhood, and policy-level factors associated with suboptimal child passenger safety practices in motor vehicle collisions (MVCs) with a fatality. The analysis included data from child passengers (younger than 13 years old) in cars and light trucks with known restraint status and seating location identified from the Fatality Analysis Reporting System database (2011 to 2021).
The researchers found that 73.3 percent had a known restraint (29.4 percent child passenger restraint system, 50.7 percent seatbelt, 19.9 percent unrestrained) and seating position (15.2 percent in front seat). Among 26,731children, those aged 4 to 12 years had the highest proportion of suboptimal practices identified. The strongest predictors of suboptimal practices were child age (4 to 7 years versus younger than 4 years: odds ratio, 1.10) and vehicle over capacity (odds ratio, 1.09). With increasing vehicle model year, Child Opportunity Index level, fines, and law scores, there was a decrease in suboptimal child passenger safety practices. Seventy-five counties were identified as hotspots for overall suboptimal practices and for premature transitions, 45 were hotspots for riding unrestrained, and 64 were hotspots for traveling in the front seat.
"Given the continued problem of suboptimal child passenger safety practices among children across the country, there is a need for innovative, targeted programs to promote correct and consistent use of age-appropriate car seats, restraints, and seating locations," Kozhumam said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-13 12:00
Read more

- Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer
- Blowing Conch Shell Tied to Improved Obstructive Sleep Apnea Measures
- What Are The Best Treatments For Chronic Hives?
- FDA Warns About Safety Issues With Boston Scientific Heart Devices
- Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
- Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions